Earnings Call for Q4FY22 of Meghmani Finechem
Conference Call with Meghmani Finechem Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.25-04-2022
25-04-2022
Q4FY22 Quarterly Result Announced for Meghmani Finechem Ltd.
Meghmani Finechem posts highest ever revenue of Rs 1,551 crore in Q4FY22, and highest net profit of Rs 253 crore Specialty Chemicals firm Meghmani Finechem declares Q4FY22 result: FY2022 Highlights: Revenue up by 87% to Rs 1,551 Cr, backed by higher sales volume of Caustic Soda and H2O2 and improved realisation for all the products EBITDA increased by 95% to Rs 509 Cr; EBITDA margin improved marginally at 33% (32% in FY21) despite inflationary pressure on raw material prices PAT increased by 151% to Rs 253 Cr and PAT margin was up by 413 bps to 16% ROCE and ROE of the company improved to 29% (16% in FY21) and 36% (16% in FY21) respectively Q4FY22 Highlights: On YoY basis, revenue up by 93% to Rs 499 Cr on account of higher realizations for all the products EBITDA increased by 118% to Rs 175 Cr (Rs 80 Cr in Q4FY21) and EBITDA margin was up by 405 bps to 35%, despite high inflationary pressure on raw materials PAT increased by 202% to Rs 99 Cr (Rs 33 Cr in Q4FY21) and PAT margin was up by 712 bps to 20% Commenting on the results Mr Maulik Patel; Chairman and Managing Director – MFL said: This has been a landmark year for MFL. We made a debut on stock exchange as an independent entity in August 2021. I am pleased to announce, we have delivered record financial performance. We have achieved highest ever Revenue & PAT of Rs 1,551 Cr and Rs 253 Cr. This is a testimony of our team's effort of delivering excellence despite the tough external environment. Our strong operational efficiency and internal cost control measures allowed us to maintain margins even with the inflationary pressure. I am happy to announce a 5-year vision of achieving Rs 5,000 crores in revenue by FY27, translating to a revenue CAGR of 25% from hereon. This growth will come from higher revenue contribution of value-added derivatives & specialty chemical. We have announced to enter in Chlorotoluene & its value chain and in phased manner we will keep on announcing our further capex in the future. We continue to move forward in our strategic direction of expanding scale, strengthening integration and achieving low cost of operations. Result PDF25-04-2022
Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation
Earnings Presentation for audited Financial Results of 04 & FY2225-04-2022
Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release for audited Financial Results of 04 & FY2225-04-2022
Meghmani Finechem Ltd - 543332 - Financial Results As On 31.03.2022.
Standalone and Consolidated Audited Financial Results for the Quarter/ Year ended 31st March, 2022.25-04-2022
Meghmani Finechem Ltd - 543332 - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th April,2022
Outcome of Board Meeting held on 25th April,202225-04-2022
Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q4 FY22 Earnings Conference Call - 25th April, 2022.21-04-2022
Meghmani Finechem Ltd - 543332 - Clarification
Meghmani Finechem Ltd has submitted to BSE a copy of Clarification is enclosed.21-04-2022
Meghmani Finechem Ltd - 543332 - Clarification sought from Meghmani Finechem Ltd
The Exchange has sought clarification from Meghmani Finechem Ltd on April 21, 2022, with reference to Movement in Volume.The reply is awaited.21-04-2022